Physician profile
John E Murphy
NPI 1760472369
$1,636.56
in general payments reported to CMS, 2019-2025
10 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $266 · 2021: $250 · 2022: $93.10 · 2023: $161 · 2024: $292 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $677.16 | 2019-2025 | Precision 1, Precision7, Total30 |
| Glaukos Corporation | $392.28 | 2019-2023 | |
| Coopervision INC. | $163.57 | 2021-2025 | Myday Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $156.30 | 2021 | |
| Sun Pharmaceutical Industries INC. | $96.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $54.26 | 2021 | |
| Kala Pharmaceuticals, INC. | $29.52 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $28.52 | 2025 | Xdemvy |
| Dompe US, INC. | $27.18 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.